PRR22
Proline-rich protein 22
Also known as: MGC24975, PRR22_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IZ63
- Gene
- PRR22
- Ensembl
- ENSG00000212123
- Chromosome
- 19
- Canonical length
- 422 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Cytosol
OverviewNCBI Gene
No narrative summary is available for PRR22 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
422 residues, UniProt reviewed canonical sequence.
>Q8IZ63|PRR22
1 MQHPKPFCAP AAPQEGFSPQ SLEGAEVLGN QPAPTCAEPP PAMGSLNLYH PPDPEKEVFP
61 APPAGFQMAP CGCFFDPRIY RIEWTTPDLG QSALYKLAAS SGGPAGVPSA PGSYLLEPQP
121 YLKAPGLPPY PHYQQAPGGP QFLLPYFPPE GPGPEALGFV GDAGPAAFVE LPLPPLEEGP
181 APLPPPPPKE NKPPPVLITL PAEPTLPPDA YSHLQGHLGH FPGPEPLAFP VKELQGSGAR
241 PGVPLYPPGL SELKVAEVKE GALLGAGKAK APKTARALAL PDKVLLEDAM KLFDCLPGAS
301 EPEGTLCEVP GPALPDSSGG NSADDIRSLC LPEELLSFDY SVPEILDTVS NVDYFFNFKA
361 LDEEQPPHPG PPATNTPAPI LSGKRKASTA KKGKPGRKAR QPAGPASATP PGPREDLGAT
421 PHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRR22 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.7
- Highest tissue expression
- 48 nTPM
Expression across tissuesHPA
Tissue
- testis: 48 nTPM
- liver: 12 nTPM
- kidney: 7 nTPM
- prostate: 6.7 nTPM
- spleen: 6.3 nTPM
- pancreas: 6 nTPM
Single-cell type
- early spermatids: 174 nCPM
- late primary spermatocytes: 165 nCPM
- late spermatids: 114 nCPM
- retinal horizontal cells: 10 nCPM
- undifferentiated spermatogonia: 8.1 nCPM
- early primary spermatocytes: 7.8 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 4.4 nTPM
- cerebral cortex: 4.1 nTPM
- medulla oblongata: 4 nTPM
- thalamus: 4 nTPM
- basal ganglia: 3.9 nTPM
- amygdala: 3.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.63
- gnomAD pLI
- 0.01
- gnomAD missense Z
- -0.01
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
- Proline-rich protein 22
- Proline-rich protein family 22
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRR22 as an antibody target. Whether an autoantibody or antibody against PRR22 could matter depends on whether native PRR22 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRR22 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRR22 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...